---
schema_version: "secwatch.filing_event.v1"
accession: "0001651944-24-000060"
form_type: "8-K"
ticker: null
cik: "0001651944"
company_name: "DermTech, Inc."
filed_at: "2024-06-18T23:59:59+00:00"
generated_at: "2026-06-01T03:54:39.336548+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# DermTech files for Chapter 11 bankruptcy; will seek sale of assets

## Summary
- Filed Chapter 11 petition in Delaware Bankruptcy Court on June 18, 2024; intends to sell substantially all assets.
- Reduced workforce by ~20% (15 employees) on June 12, 2024, with estimated $0.6M in severance costs.
- Entered retention agreements with CEO ($510K), CFO ($349K), CCO ($200K), and GC ($331K) tied to continued employment.
- Company cautions equity holders will likely experience a complete loss on their investment.
- Laboratory operations and DermTech Melanoma Test orders continue during bankruptcy process.

## SEC filing metadata
- accession: 0001651944-24-000060
- form_type: 8-K
- cik: 0001651944
- company_name: DermTech, Inc.
- filed_at: 2024-06-18T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.03, 2.05, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000060/0001651944-24-000060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000060/dmtk-20240612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001651944-24-000060
- JSON: https://secwatch.observer/filing/0001651944-24-000060.json
- Plain text: https://secwatch.observer/filing/0001651944-24-000060.txt

## Key facts
- Distress & Bankruptcy
  DermTech, Inc. entered chapter 11 in United States Bankruptcy Court for the District of Delaware (petition 2024-06-18).
  - Proceeding: chapter 11
  - Court: United States Bankruptcy Court for the District of Delaware
  - Petition: 2024-06-18
  source text: On June 18, 2024, after considering various strategic alternatives, DermTech, Inc. and its subsidiary, DermTech Operations, Inc. (together, the “Company” or “DermTech”) filed voluntary petition for relief under Chapter 11 of Title 11 (“Chapter 11”) of the United States Bankruptcy Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”), thereby commencing a Chapter 11 case for the Company - In re DermTech, Inc., et. al. (Bankr. D. Del.) .
  evidence_url: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000060/0001651944-24-000060-index.htm
- Restructurings & Charges
  DermTech, Inc. announced a restructuring with charges of approximately $0.6 million (approximately 15 employees (approximately 20% of the Company’s workforce)).
  - Type: restructuring
  - Charge: approximately $0.6 million
  - Headcount: approximately 15 employees (approximately 20% of the Company’s workforce)
  source text: On June 12, 2024, the Board of Directors (the “Board”) of the Company approved a reduction in force (the “Reduction in Force”) of approximately 15 employees (approximately 20% of the Company’s workforce), with potential additional reductions of DermTech’s workforce in the future, in order to reduce the Company’s operating expenses and in an effort to preserve value for stakeholders. The Company estimates that it will incur aggregate pre-tax charges of approximately $0.6 million in connection with the Reduction in Force, primarily consisting of severance payments, employee benefits and related costs.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1651944/000165194424000060/0001651944-24-000060-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.